Are you Dr. Takenouchi?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 15 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
New York, NY 10065Phone+1 212-746-3332Fax+1 212-746-4001
Summary
- Dr. Toshiki Takenouchi, MD is a Child Neurologist in New York, New York. He is currently licensed to practice medicine in Connecticut and Hawaii.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Residency, Child Neurology, 2002- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2006 - 2009
Brooklyn Hospital CenterInternship, Transitional Year, 2005 - 2006
Keio Gujuku University School of MedicineClass of 2002
Certifications & Licensure
CT State Medical License 2009 - 2025
HI State Medical License Active through 2014- American Board of Pediatrics Pediatrics
- American Board of Psychiatry and Neurology Neurology with Special Qualification in Child Neurology
Publications & Presentations
PubMed
- Biallelic loss-of-function variants in the centriolar protein CCP110 leads to a ciliopathy-like phenotype.Hisato Suzuki, Yukako Muramatsu, Fuyuki Miya, Hideyuki Asada, Mamiko Yamada
European Journal of Medical Genetics. 2024-08-01 - 8 citationsGenome Analysis in Sick Neonates and Infants: High-yield Phenotypes and Contribution of Small Copy Number Variations.Hisato Suzuki, Masatoshi Nozaki, Hiroshi Yoshihashi, Kazuo Imagawa, Daigo Kajikawa
The Journal of Pediatrics. 2022-05-01 - 4 citationsMultiple introductions of SARS-CoV-2 B.1.1.214 lineages from mainland Japan preceded the third wave of the COVID-19 epidemic in HokkaidoTakako Shimura, Kodai Abe, Toshiki Takenouchi, Mamiko Yamada, Hisato Suzuki
Travel Medicine and Infectious Disease. 2021-11-01
Press Mentions
Excelra Collaborates with Keio University on Drug Repurposing to Explore New Therapeutics for a Rare IndicationDecember 17th, 2019- Study Touts Rapid Genome Testing in NICUsMarch 4th, 2024
